The effect of royal jelly on prevention of postmenopausal bone loss.
Not Applicable
- Conditions
- Postmenopausal bone loss
- Registration Number
- JPRN-UMIN000017629
- Lead Sponsor
- Aichi Medical University School of Medicine
- Brief Summary
1) Although women in the placebo group experienced a significant loss of BMD and deterioration in HSA parameters of the femur, no significant differences were found in these parameters in women in the RJ group. 2) The levels of P1NP and TRACP-5b decreased significantly in the placebo group; however, the total P1NP level, a marker of bone formation, was not significantly different in the RJ group at postintervention compared with baseline.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 72
Inclusion Criteria
Not provided
Exclusion Criteria
Women who are allergic to royal jelly, women with asthma, women who have complications and medications that would affect bone metabolism, and women who need osteoporosis medication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone mineral density, bone turnover markers
- Secondary Outcome Measures
Name Time Method